September 21, 2017 8:49 AM ET

Biotechnology

Company Overview of Cirius Therapeutics, Inc.

Key Executives for Cirius Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Robert F. Baltera Jr., M.S., M.B.A.37 RelationshipsChief Executive Officer and Director52
Jerry Colca Ph.D.11 RelationshipsCo-Founder and Vice President of Research & Development--
Howard C. Dittrich M.D., F.A.C.C.10 RelationshipsChief Medical Officer63
Brian K. Farmer No RelationshipsChief Business Officer44

Cirius Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. Baltera Jr., M.S., M.B.A. 37 RelationshipsCirius Therapeutics, Inc.52
Daniel J. Estes Ph.D. 27 RelationshipsFrazier Healthcare Partners36
Michael J. Jandernoa 149 RelationshipsRobertson Global Health Solutions Corporation67
Nilesh Kumar Ph.D. 54 RelationshipsNovo A/S--
David L. Van Andel 28 RelationshipsVan Andel Institute57
View All Board Members

Cirius Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
392.6K
Bonus
238.0K
Total Short Term Compensation
488.0K
Total Value of Options
18.4M
Compensation as of Fiscal Year
Cirius Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

VALBIOTIS Appoints Jean Zetlaoui on Valbiotis to Supervisory Board
September 20, 2017 5:30 AM ET
Sirtex Medical Limited Announces Board Changes
September 19, 2017 10:21 PM ET
FibroGen, Inc. Appoints Gerald Lema to Board of Directors
September 19, 2017 8:35 PM ET
Intarcia Therapeutics, Inc. Announces Board Changes
September 19, 2017 8:10 PM ET
GT Biopharma, Inc. Appoints Thomas N. Chase as Advisor to the Board of Directors
September 19, 2017 1:44 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cirius Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.